Astralytix
PrivateLast Round
Accelerator
May 19, 2026
Total Funding Raised
$20,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Astralytix operates in Healthcare & Life Sciences and is based in Leuven. Its latest recorded funding round was an Accelerator round in May 2026.
Astralytix is a biotechnology company that develops FibriLysin technology to create next-generation antimicrobials for treating resistant staphylococcal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astralytix Comparables
Compare Astralytix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Obulytix | 83% | |
| Resistia | 81% | |
| PrecisioBiotix Therapeutics | 79% |
For institutional investors. Book with your work email.
Astralytix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 19, 2026 | ||||
| Grant | Mar 4, 2026 |
For institutional investors. Book with your work email.
Astralytix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
$10K raised from INCATE accelerator.
- Mar 4, 2026
Secured $10K in grant funding.
For institutional investors. Book with your work email.
Astralytix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Astralytix's valuation, stock price, and market status.
Is Astralytix a public or private company?
Astralytix is a private company.
What is the current stock price of Astralytix?
Astralytix is a private company, so its shares have no public market price. Caplight tracks Astralytix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Astralytix worth (valuation)?
Valuation information for Astralytix is not publicly available.
Can I buy Astralytix stock?
Astralytix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Astralytix's last funding round?
Astralytix's most recent funding round was Accelerator on May 19, 2026.
Who are the main investors in Astralytix?
Key investors in Astralytix include INCATE.
Will Astralytix IPO soon?
No public IPO plans have been announced for Astralytix.
How can I track Astralytix secondary market activity?
Caplight tracks bids, offers, and trades in Astralytix's shares on secondary markets.